Novartis
A Senior Scientist II in the Chemical Biology group at Novartis will design and execute innovative strategies to explore emerging modalities in induced proximity and validate mechanisms of action. The role involves integrating biochemical, cellular, and omics-based approaches to generate high-quality data that guides drug discovery program prioritization. Success requires strong hands-on expertise in molecular and cellular biology combined with the ability to analyze complex biological datasets.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Right around the average for this role
R-251294 Principal Scientist – Chemical Biology & Proximity-Based Therapeutics
Amgen
Senior Principal Scientist – Chemical Biology & Proximity-Based Therapeutics
lifelancer
Research Assistant for the Metabolic Liver Disease Lab
National University of Singapore
Scientist, Induced Proximity Drug Discovery
Birdwood Therapeutics
Dean’s Distinguished Postdoctoral Fellowship in Chemical Biology and Drug Discovery
The Ohio State University
Postdoctoral Fellow-Discovery Proteomics
Amgen